
U.S. Surgeon General Jerome Adams attends a roundtable on donating plasma Thursday, July 30, 2020, at the American Red Cross-National Headquarters in Washington, D.C. (Official White House Photo by Tia Dufour)
On his Substack blog, The Dossier, Jordan Schachtel raises the alarm over former Surgeon General, Dr. Jerome Adams, and his jump “into the Perpetual Pandemic industry.” Schachtel writes:
The runaway train disaster that was the original White House Coronavirus Task Force had quite a few utterly comical figures that we’ve reported on extensively in The Dossier. From the infamous tag team of Dr Fauci and Dr Birx, to Robert Redfield and Stephen Hahn, you can easily fill a clown car with the amount of ridiculous figures that were in the room at any given time.
And while not as high profile an appointee, former Surgeon General Dr. Jerome Adams was easily one of its most destructive selections. As the former Health Commissioner of Indiana, Adams goes way back with former VP Mike Pence. He has long been the politician’s “Public Health” apprentice. Pence is credited with getting Adams the Surgeon General gig and his position on the task force.
Like his colleagues in the previous administration, Adams has cashed in big time on his largely ceremonial post in the Trump White House.
He is now Purdue University’s “Executive Director of Health Equity Initiatives,” the first of its kind gig at the public university.
In May, Adams was appointed chairman of the board of a company called Total Diversity Clinical Trial Management. The company describes itself as “a full-service CRO and Diversity Organization with an integrated focus on support services highlighting diversity and inclusion in clinical trials.”
In June, Adams joined the board of Avita, an outfit that claims “deep expertise” in providing “LGBTQ+ care.”
Adams is also diving head first into the Perpetual Pandemic industry.
By Jordan Schachtel, The Dossier
Read more here.
If you’re willing to fight for Main Street America, click here to sign up for my free weekly email.